Biocardia to participate in cantor fitzgerald's cell and genetic medicines conference

Sunnyvale, calif., sept. 08, 2022 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], today announced it will participate on a panel as a presenting company at cantor fitzgerald's cell and genetic medicines conference. the conference is being held in person on september 15, 2022, at the lotte new york palace hotel in new york city located at 455 madison avenue.

BCDA Ratings Summary

BCDA Quant Ranking